ERBB2 and breast cancer: In ERα-positive T47-D and MCF-7 human breast cancer cells, overexpression of ERβ not only attenuated Akt signaling via down-regulation of ErbB2/ErbB3 but also improved the sensitivity of these cancer cells to tamoxifen [135].